Related Compounds
Compounds connected by the same goals, effects, or research topics.
Herb Profile
Yohimbe
Pausinystalia johimbe
Yohimbe is represented here as a bark derived monograph anchored to yohimbine, an alpha 2 adrenergic antagonist with sympathomimetic effects.
Last reviewed: •3 sources citedReport a correctionProfile-wide ·C Limited
Use extra caution — High risk stimulant herb. Details
- Evidence
- Limited Evidence
- Typical onset
- Varies by prep
- Safety rating
- High caution
- Best for
- Sleep, Stress, Cognitive function
- Avoid / review if
- Hypertension, Arrhythmia, Heart Disease
At a glance
From this profile's structured data- Evidence
- Grade C
- Safety
- High-risk stimulant herb.
- Profile context
- sleep, stress
Next stepsWhere to go next — guides & comparisons
Continue reading
- If you want help sleeping → Sleep guides
- If you want to browse more herbs → All herbs
Safety
Safety & Cautions
High risk stimulant herb. Reported adverse events include anxiety, agitation, hypertension, tachycardia, GI distress, and rare serious cardiovascular/neurologic events.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
- Liver-SensitiveLiver-related caution language appears in the profile.
- Stimulant-Like ProfileStimulant-like or activating caution language is present.
- Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields
Pregnancy, breastfeeding, and contraindications
- Hypertension
- Arrhythmia
- Heart Disease
- Anxiety/Panic Disorder
- Bipolar Disorder/Mania
- Kidney Or Liver Disease
- Pregnancy/Breastfeeding.
- Avoid With Stimulants
- Decongestants
- MAOIs
Safety classifications
- Liver-Sensitive: Liver-related caution language appears in the profile.
- Stimulant-Like Profile: Stimulant-like or activating caution language is present.
- Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.
Full safety note
- High risk stimulant herb. Reported adverse events include anxiety, agitation, hypertension, tachycardia, GI distress, and rare serious cardiovascular/neurologic events.
Safety labels
- Liver-Sensitive
- Stimulant-Like Profile
- Pregnancy/Breastfeeding Caution
Evidence-based safety
Caution when combined
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
High-Priority Caution
26 flagged pairingsSerotonergic activity
High-Priority Caution
26 flagged pairingsSerotonergic activity
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Serotonergic activityCertainty: Theoretical
Data provenance recorded for 26 of 26 pairings in this mechanism group.
- 5-HTP — Theoretical interaction certainty
- Caffeine — Theoretical interaction certainty
- crocetin — Theoretical interaction certainty
- crocin — Theoretical interaction certainty
- Crocus Sativus — Theoretical interaction certainty
- Damiana — Theoretical interaction certainty
- DMT — Theoretical interaction certainty
- Ginkgo — Theoretical interaction certainty
- Panax Red Ginseng — Theoretical interaction certainty
- Panax White Ginseng — Theoretical interaction certainty
- Harmaline — Theoretical interaction certainty
- Harmine — Theoretical interaction certainty
+14 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Moderate Caution
81 flagged pairingsBlood-pressure effects
Moderate Caution
81 flagged pairingsBlood-pressure effects
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Blood-pressure effectsCertainty: Theoretical
Data provenance recorded for 81 of 81 pairings in this mechanism group.
- Agmatine sulfate — Theoretical interaction certainty
- ajoene — Theoretical interaction certainty
- Allicin — Theoretical interaction certainty
- American Ginseng Extract — Theoretical interaction certainty
- Andrographis — Theoretical interaction certainty
- Angelica Dahurica — Theoretical interaction certainty
- Astaxanthin — Theoretical interaction certainty
- Astragalus Membranaceus — Theoretical interaction certainty
- Beetroot extract — Theoretical interaction certainty
- Berberis — Theoretical interaction certainty
- Bicarbonate — Theoretical interaction certainty
- Black Seed — Theoretical interaction certainty
+69 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence
Evidence Summary
Evidence lens
Read as directional context, not settled clinical proof.
LimitedLimited Evidence
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Neurotransmitter Modulation · Stress Response Modulation
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — High risk stimulant herb.
This profile cites 3 human studies.
Study design details
Evidence Grade
Grade C: Limited Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Narrative review
- Risk of Bias
- High
- Consistency
- Not assessed
Strongest recorded design is a narrative review, drawn from 3 recorded studies, none of which measured an outcome in people.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (3)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable
What the evidence actually shows
This table contains 3 structured sources, including 0 human evidence sources; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.
Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned
What would change our conclusion?
Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Fugh-Berman A et al. · Lancet · 2000 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
PubMed indexed authors · 2012 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Pyke RE et al. · Sex Med Rev · 2020 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Dosing & Timing
- No standardized dose
- Preparation specific; use standardized product label for Do not equate crude bark products with pharmaceutical yohimbine and require source backed dosage review before therapeutic claims.
How Yohimbe works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Yohimbe Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways
Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.
- Neurotransmitter Modulation
- Stress Response Modulation
Compare related active botanicals
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Yohimbe research notes
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Botanical profile context
How to interpret Yohimbe
Yohimbe herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first format. Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.
When reviewing Yohimbe, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.
For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.